The American journal of tropical medicine and hygiene · 2024
Cardiac Tuberculosis: A Case Series from Ethiopia, Italy, and Uganda and a Literature Review.
ОбзорКлинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cotugno Sergio, Guido Giacomo, Manco Cesari Giorgia, Ictho Jerry, Lochoro Peter, Amone James, Segala Francesco Vladimiro, De Vita Elda, Lattanzio Rossana, Okori Samuel, De Iaco Giuseppina, Girma Adisu, Sura Abata, Hessebo Eriballo Tariku, Balsemin Franco, Putoto Giovanni, Ronga Luigi, Manenti Fabio, Facci Enzo, Saracino Annalisa, Di Gennaro Francesco
Аннотация
Extrapulmonary tuberculosis (TB) is estimated to account for up to 20% of active cases of TB disease, but its prevalence is difficult to ascertain because of the difficulty of diagnosis. Involvement of the heart is uncommon, with constrictive pericarditis being the most common cardiac manifestation. Diagnostic research for cardiac disease is frequently lacking, resulting in a high mortality rate. In addition to direct cardiac involvement, instances of cardiac events during antitubercular therapy are described. This case series describes five cases of TB affecting the heart (cardiac TB) from Italy and high-burden, low-income countries (Ethiopia and Uganda), including a case of Loeffler syndrome manifesting as myocarditis in a patient receiving antitubercular therapy. Our study emphasizes how cardiac TB, rare but important in high-burden areas, is a leading cause of pericardial effusion or pericarditis. Timely diagnosis and a comprehensive approach, including imaging and microbiological tools, are crucial. Implementing high-sensitivity methods and investigating alternative samples, such as detection of tuberculosis lipoarabinomannan or use of the GeneXpert assay with stool, is recommended in TB control programs.